Incannex Healthcare Ltd ADR
Price & Volume
Stats
See more52W Range | $0.47-$3.55 |
Market Cap | $17.2M |
Shares Short | 195,642 |
Financials
See moreRevenue (12 Mos) | $98,000 |
Revenue Growth (YoY) | 29.6% |
Gross Profit (12 Mos) | $98,000 |
Diluted EPS | -$1.42 |
News
See moreYahoo Finance • 26 days ago
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
Yahoo Finance • 2 months ago
Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules
Yahoo Finance • 2 months ago
Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates
About
CEO | Mr. Joel Bradley Latham |
CFO | Mr. Joseph Swan |
Address | 8 Century Circuit, Sydney, NSW, Australia, 2153 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 9 |
